Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats

Endocrinology

Volumn 145, Issue 5, 2004, Pages 2148-2156

  Wang, Feng Sheng ^a   Wang, Ching Jen ^a   Chen, Yeung Jen ^b   Huang, Yu Ting ^a   Huang, Hui Chen ^a   Chang, Per Rong ^c   Sun, Yi Chih ^a   Yang, Kuender D ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' (HYDROXYNITROSOHYDRAZINO)BISETHANAMIDE; CALPHOSTIN C; COLONY STIMULATING FACTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; HERBIMYCIN A; NITRIC OXIDE DONOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; FEMUR; IMMUNOHISTOCHEMISTRY; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; STROMA CELL; TRANSCRIPTION REGULATION;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OSTEOCLASTS; OSTEOPROTEGERIN; OVARIECTOMY; RANK LIGAND; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 2042514317     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1074     Document Type: Article

References (39)

1. Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
2. Cummings SR, Melton III LJ 2002 Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
3. Suda T, Udagawa N, Nakmura I, Miyaura C, Takahashi N 1995 Modulation of osteodast differentiation by local factor. Bone 17:87-91
4. Hofbauer LC, Khosla S, Dunstan CR Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12
5. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Cahng MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campfell P, Boyle WJ 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
6. Yasuda H, Shima N, Nakagawa N, Mochizuki S, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337
7. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y 1998 Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091-27096
8. Saika M, Inoue D, Kido S, Matsumoto T 2001 17β-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen-receptor-α. Endocrinology 142:2205-2212
9. Chae HJ, Park RK, Chung HT, Kang JS, Kim MS, Choi DY, Bang BG, Kim HR 1997 Nitric oxide is a regulator of bone remodeling. J Pharm Pharmacol 49:897-902
10. Van Bezooijen RL, Van der Bent C, Papapoulos SE, Lowik CW 1999 Oestrogenic compounds modulate cytokine-induced nitric oxide production in mouse osteoblast-like cells. J Pharm Pharmcol 51:1409-1414
11. Fox SW, Chambers TJ, Chow JW 1995 Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol 270:955-960
12. Tsukahara H, Miura M, Tsuchida S, Hata I, Hata K, Yamamoto K, Ishii Y, Muramatsu U, Sudo M 1996 Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats. Am J Physiol 270:E840-E845
13. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Osdoby P 2000 Decrease nitric oxide levels stimulates osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J Bone Miner Res 15:474-488
14. Wimalawansa SJ 2000 Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J Bone Miner Res 15:2240-2244
15. Jamal Sam Browner WS, Bauer DC, Cumming SR 1998 Intermittent use of nitrates increases bone mineral density: the study of osteopororic fractures. J Bone Miner Res 13:1755-1759
16. Hukkanen M, Platts LAM, Lawes T, Girgis SI, Konttinen YT, Goodship AE, Maclntyre I, Polak JM 2003 Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 32:142-149
17. Rubin J, Murphy TC, Fan X, Goldschmidt M, Taylor WR 2002 Activation of extracellular signal-regulated kinase is involved in mechanical strain inhibition of RANKL expression in bone stromal cells. J Bone Miner Res 17:1452-1460
18. Wang FS, Yang KD, Chen RF, Wang CJ, Sheen-Chen SM 2002 Extracorporeal shock wave promotes growth and differentiation of bone-marrow stromal cells towards osteoprogenitor associated with induction of TGF-β1. J Bone Joint Surg Br 84:457-461
19. Wang FS, Wang CJ, Sheen-Chen SM, Kuo YR, Chen RF, Yang KD 2002 Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem 277:10931-10937
20. Wang FS, Wang CJ, Huang HJ, Chung H, Chen RF, Yang KD 2001 Physical shock wave mediates membrane hyperpolarization and ras activation for osteogenesis for human bone marrow stromal cells. Biochem Biophys Res Commun 287:648-655
21. Kobayahi K, Takahashi N, Jimi E, Udagawa N, Takami M, Katake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-285
22. Vedi S, Compston JE 1996 The effect of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone 19:535-539
23. Bord S, Ireland DC, Beavan SR, Compston JE 2003 The effect of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32:136-141
24. O'Shaughnessy MC, Polak JM, Afzal F, Hukkanen MCJ, Huang P, MacIntyre I, Buttery LDK 2000 Nitric oxide mediates 17-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun 277:604-610
25. Rosselli M, Imthurn B, Keler PJ, Jackson EK, Dubey RK 1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 25:848-853
26. Stacy E, Korkia P, Hukkanen MV, Polak JM, Rutherford OM 1998 Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J Clin Endocrinol Metab 83:3056-3061
27. Collin-Osdoby Patricia, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P 2001 Receptor activator of NFκB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 276:20659-20672
28. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegrin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endorcrinology 140:4382-4389
29. van't Hof RJ, Ralston SH 1997 Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclastic progenitor and suppressing osteoclast activity. J Bone Miner Res 12:1797-1804
30. Holiday LS, Dean AD, Lin AH, Greenwald JE, Gluck SL 1997 Low NO concentrations inhibits osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol 273:283-291
31. Mancini L, Moradi-Bidhendi N, Becherini L, Martineti V, MacIntyre I 2000 The biphasic effect of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun 274:477-481
32. Chen RM, Liu HC, Lin YL, Jean WC, Chen JS, Wang JH 2002 Nitric oxide induced osteoblast apoptosis through the de novo synthesis of Bax protein. J Orthop Res 20:295-302
33. Kondo H, Guo J, Bringhurst FR 2002 Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res 17:1667-1679
34. Yang X, Halladay D, Onyia JE, Martin TJ, Chandrasekhar S 2002 Protein Kinase C is a mediator of the synthesis and secretion of osteoprotegerin in osteoblast-like cells. Biochem Biophys Res Commun 290:42-46
35. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754
36. Thirunavukkarasu K, Jallday DL, Miles RR, Yang X, Galvin RJS, Chandrasekhar S, Martin TJ, Onyia JE 2000 The osteoblastic-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275:25163-15172
37. Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A 1998 Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 27:697-702
38. Jilka RL, Hangoc GF, Girasole G, Passen G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
39. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R 1996 Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271:28890-28897